Capital Analysts LLC’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$117K Hold
1,633
﹤0.01% 758
2025
Q4
$134K Sell
1,633
-19
-1% -$1.48K ﹤0.01% 697
2025
Q3
$124K Buy
1,652
+280
+20% +$20.9K ﹤0.01% 682
2025
Q2
$102K Buy
1,372
+271
+25% +$18.9K ﹤0.01% 664
2025
Q1
$89K Sell
1,101
-83
-7% -$7.13K ﹤0.01% 663
2024
Q4
$93K Buy
1,184
+3
+0.3% +$255 ﹤0.01% 625
2024
Q3
$111K Buy
1,181
+60
+5% +$5.04K ﹤0.01% 570
2024
Q2
$87K Buy
1,121
+13
+1% +$1.06K ﹤0.01% 599
2024
Q1
$101K Buy
1,108
+651
+142% +$54.2K ﹤0.01% 548
2023
Q4
$35K Buy
457
+413
+939% +$28.9K ﹤0.01% 723
2023
Q3
$3K Sell
44
-30
-41% -$2.18K ﹤0.01% 1019
2023
Q2
$6K Buy
74
+31
+72% +$2.47K ﹤0.01% 870
2023
Q1
$3K Buy
+43
New +$3.07K ﹤0.01% 900

Other funds holding GEHC

Capital Analysts LLC's GEHC Position: Q1 2026 in Review

Capital Analysts LLC held its GE HealthCare (GEHC) position steady in Q1 2026 at 1,633 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #758.

Capital Analysts LLC first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $134K in Q4 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Capital Analysts LLC held 1,633 shares of GE HealthCare worth $117K as of Q1 2026.
  • Capital Analysts LLC left its GE HealthCare share count unchanged in Q1 2026.
  • GE HealthCare made up ﹤0.01% of Capital Analysts LLC's portfolio in Q1 2026, its #758 holding.
  • Capital Analysts LLC first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Capital Analysts LLC's GE HealthCare position peaked at $134K in Q4 2025.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.